RARB and osteosarcoma: We further demonstrated that the inhibitory effects of these chemicals on osteosarcoma is achieved by specifically targeting corresponding NRs, suggesting that the NRs RARb, PPARg, LXR and Rev-Erba are potential therapeutic targets for osteosarcoma treatment and revealing their roles in regulating osteosarcoma cell growth.